Grippol® Plus is a trivalent influenza vaccine containing the antigens of two type A viruses and one type B virus.
In addition to the antigens, it also contains azoximer bromide. It acts as an adjuvant, i.e. a substance that
stimulates the immune response to antigens when the vaccine is administered, and thus contributes to its
effectiveness. The addition of azoximer bromide reduces the number of antigens in the vaccine while maintaining
efficacy and improving the safety profile.
Grippol® Plus contains no preservatives or antibiotics, which reduces the risk of local reactions to the
vaccination. Due to these properties, Grippol® Plus is indicated for preventive vaccinations for all categories of
citizens, including children over 6 months of age, pregnant women, persons with chronic diseases, the elderly,
highly allergic individuals, and immunodeficient persons.
The antigenic composition of the Grippol® plus vaccine is updated annually according to WHO recommendations and
forecasts of the circulation of influenza virus strains of northern hemisphere influenza season.
Grippol® Quadrivalent is a quadrivalent vaccine that protects against two strains of type A viruses and two strains
of influenza B virus (Victoria and Yamagata). Compared to trivalent vaccines, the addition of the 4th strain to the
Grippol® Quadrivalent provides greater protection against influenza virus In both lines. The efficacy of flu
vaccination with Grippol® Quadrivalent is due to the content of Polyoxidonium® as an adjuvant. Protecting against
more strains of influenza virus, the vaccine has a high safety profile due to its reduced antigen content, as
confirmed by clinical trials conducted to world standards.
Grippol® Quadrivalent is available in syringes for single individual use, and is recommended for people aged 6 to 60
with a high risk of influenza infection. These are employees of health care institutions, education and public order
services, the military, social and welfare services, catering, trade services, as well as workers and engineers from
all sectors of industry.
The vaccine contains no preservatives or antibiotics.